InsiderClue
← All stocks

Axsome Therapeutics, Inc.

AXSM Mostly scheduled
CIK 0001579428 #896 in the set updated 17 Sep 2026
Bought (120 mo)
$1.56M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$194.52M
$23.44M on a plan · $170.75M straight out of an exercise
Sold at will
$322.47K
1 of 73 sales
Net
−$192.96M
+$1.24M against sales at will

By person

9 insiders · 117 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
TABUTEAU HERRIOT
Chief Executive Officer
—
$110.58M (20) scheduled
−$110.58M
7,229
0.0138%
$1.51M
0.0%
Jacobson Mark L.
Chief Operating Officer
—
$28.81M (13) scheduled
−$28.81M
0
0.0000%
$0.00
—
JEFFS ROGER
Director
$147.35K (1)
$15.77M (11) scheduled
−$15.63M
58,367
0.1114%
$12.18M
+1,234%
Pizzie Nick
Chief Financial Officer
$351.24K (11)
$12.13M (4) scheduled
−$11.78M
43,009
0.0821%
$8.97M
+5,435%
Coleman Mark
Director
$866.84K (11)
$12.33M (12) scheduled
−$11.46M
434,245
0.8290%
$90.61M
+9.1%
Saad Mark E
Director
$192.08K (5)
$8.35M (4) scheduled
−$8.16M
11,531
0.0220%
$2.41M
+249.2%
Murdock Hunter R.
General Counsel
—
$3.65M (5) scheduled
−$3.65M
0
0.0000%
$0.00
—
Maizel Ari
Chief Commercial Officer
—
$2.75M (2) scheduled
−$2.75M
0
0.0000%
$0.00
—
Mahony Susan
Director
—
$145.02K (2) scheduled
−$145.02K
829
0.0016%
$172.97K
—

Individual transactions

28
Insider
Date
Role
Action
Shares
Price
Amount
Coleman Mark
8 Sep 2025
Director
Buy
488
$127.40
$62.17K
Coleman Mark
8 Sep 2025
Director
Buy
287
$127.30
$36.54K
Coleman Mark
8 Sep 2025
Director
Buy
800
$127.20
$101.76K
JEFFS ROGER
19 Nov 2021
Director
Buy
3,950
$37.30
$147.35K
Coleman Mark
18 Nov 2021
Director
Buy indirect
1,021
$35.10
$35.84K
Coleman Mark
18 Nov 2021
Director
Buy indirect
409
$35.07
$14.34K
Pizzie Nick
18 Nov 2021
CHIEF FINANCIAL OFFICER
Buy indirect
142
$35.20
$5.00K
Pizzie Nick
18 Nov 2021
CHIEF FINANCIAL OFFICER
Buy indirect
145
$34.30
$4.97K
Pizzie Nick
18 Nov 2021
CHIEF FINANCIAL OFFICER
Buy indirect
141
$35.43
$5.00K
Pizzie Nick
18 Nov 2021
CHIEF FINANCIAL OFFICER
Buy
527
$35.50
$18.71K
Saad Mark E
17 Nov 2021
Director
Buy indirect
100
$34.40
$3.44K
Saad Mark E
17 Nov 2021
Director
Buy indirect
100
$34.45
$3.45K
Saad Mark E
17 Nov 2021
Director
Buy indirect
100
$34.40
$3.44K
Saad Mark E
17 Nov 2021
Director
Buy
3,000
$34.53
$103.60K
Coleman Mark
12 May 2021
Director
Buy indirect
500
$58.15
$29.08K
Pizzie Nick
29 Jun 2020
Chief Financial Officer
Buy
777
$76.64
$59.55K
Coleman Mark
29 Jun 2020
Director
Buy
650
$78.50
$51.03K
Pizzie Nick
26 Sep 2019
Chief Financial Officer
Buy
2,180
$24.80
$54.06K
Coleman Mark
26 Jun 2019
Director
Buy
15,800
$23.10
$364.98K
Coleman Mark
25 Jun 2019
Director
Buy
400
$23.25
$9.30K
Pizzie Nick
11 Jun 2019
Chief Financial Officer
Buy
1,920
$20.80
$39.94K
Saad Mark E
23 May 2019
Director
Buy
3,500
$22.33
$78.16K
Coleman Mark
13 May 2019
Director
Buy
4,650
$21.44
$99.70K
Coleman Mark
19 Mar 2019
Director
Buy indirect
5,100
$12.18
$62.12K
Pizzie Nick
19 Mar 2019
Chief Financial Officer
Buy
5,340
$12.58
$67.18K
Pizzie Nick
19 Mar 2019
Chief Financial Officer
Buy indirect
60
$12.69
$761.40
Pizzie Nick
19 Jun 2018
Chief Financial Officer
Buy
30,600
$3.10
$94.86K
Pizzie Nick
19 Jun 2018
Chief Financial Officer
Buy
400
$3.05
$1.22K
Show all 117 transactions →

What was left out

Form 4 filings counted 178
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 53
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,185,486
History held since 17 Mar 2017